US regulators are moving sharply to ease the early stages of drug development, despite safety concerns. Meredith Wadman reports.
This is a preview of subscription content, log in via an institution to check access.
Related links
Related links
Related links in Nature Research
London's disastrous drug trial has serious side effects for research
Earlier drug tests on people could be unsafe, critics warn
Related external links
Rights and permissions
About this article
Cite this article
Drive for drugs leads to baby clinical trials. Nature 440, 406–407 (2006). https://doi.org/10.1038/440406a
Published:
Issue Date:
DOI: https://doi.org/10.1038/440406a
- Springer Nature Limited